NattoPharma: Minutes of Meeting from Ordinary Annual General Meeting held May 20th 2016

Please see attached minutes of meeting from the Ordinary Annual General Meeting
in NattoPharma ASA, held on May 20th2016.
For more information, please contact:

Kjetil Ramsøy

CFO, NattoPharma

E-mail: kjetil.ramsoy@nattopharma.com

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

About NattoPharma and MenaQ7®

NattoPharma ASA, based in Norway, is the world's leader in vitamin K2 R&D.
NattoPharma is the exclusive international supplier of MenaQ7® Vitamin K2 as MK
-7, the best documented, commercially available Vitamin K2 as MK-7 with
guaranteed actives and stability, clinical substantiation, and international
patents granted and pending. The company has a multi-year research and
development program to substantiate and discover the health benefits of vitamin
K2 for applications in the marketplace for functional food and dietary
supplements. With a global presence, the company established its North American
subsidiary, NattoPharma USA, Inc., in Metuchen, NJ.

For more information, visit www.nattopharma.com or www.Menaq7.com